FinancialContent is the trusted provider of stock market information to the media industry.
Bears REASONS TO SELL
December 10, 2013
(Stock Blog Hub, 2/25/13)
Vivus, Inc. (VVUS) recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) re-examined and...(read more)
(Stock Wizard, 1/7/13)
Shares of Vivus Inc (NASDAQ: VVUS) surged as much as 10% on Monday after the company disclosed in a regulatory filing that prescriptions for its flagship obesity drug Qsymia jumped 68% to 12,978 for... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
(Stock Blog Hub, 11/9/12)
Vivus Inc. (VVUS) reported a loss of 40 cents per share in the third quarter of 2012, wider than the Zacks Consensus Estimate of a loss of 33 cents and the year-ago loss of 10 cents...(read more)
Vivus (VVUS) Company Overview
There is no analysis for VVUS yet. But you can go to Wikinvest to help create one!